Activated prothrombin complex concentrate for reversal of oral factor Xa inhibitors at a level 1 trauma center

被引：1
|
作者：
Bobby, Lauren [1 ]
Westlake, Evan [1 ]
Esplin, Nathan [2 ]
Young, Sarah [1 ]
机构：
[1] Allegheny Gen Hosp, Dept Pharm, 320 North Ave, Pittsburgh, PA 15212 USA
[2] Allegheny Gen Hosp, Dept Neurosurg, 320 North Ave, Pittsburgh, PA 15212 USA
来源：
THROMBOSIS RESEARCH | 2021年 / 206卷
关键词：
Apixaban; Rivaroxaban; Reversal; Activated prothrombin complex concentrate (aPCC); Intracranial hemorrhage (ICH); Andexanet alfa; ANTICOAGULANTS; MANAGEMENT; OUTCOMES; FEIBA;
D O I：
10.1016/j.thromres.2021.08.005
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：33 / 35
页数：3
相关论文
共 50 条
  • [21] EVALUATION OF 4-FACTOR PROTHROMBIN COMPLEX CONCENTRATE DOSING FOR FACTOR XA INHIBITOR REVERSAL
    Craven, Cody
    Sbertoli, Robert
    Ramiro, Joanna
    Emery, Darrick
    Braun, James
    CRITICAL CARE MEDICINE, 2021, 49 (01) : 436 - 436
  • [22] Reversal of New, Factor-specific Oral Anticoagulants by rFVIIa, Prothrombin Complex Concentrate and Activated Prothrombin Complex Concentrate: A Review of Animal and Human Studies
    Lee, Frank M. H.
    Chan, Anthony K. C.
    Lau, Keith K.
    Chan, Howard H.
    THROMBOSIS RESEARCH, 2014, 133 (05) : 705 - 713
  • [23] Four-factor Prothrombin Complex Concentrate for Reversal of Factor Xa Inhibitors versus Warfarin in Life-threatening Bleeding
    Rech, Megan A.
    Masic, Dalila
    Hammond, Drayton A.
    WESTERN JOURNAL OF EMERGENCY MEDICINE, 2021, 22 (02) : 163 - 169
  • [24] Safety of 4-factor prothrombin complex concentrate (4F-PCC) for emergent reversal of factor Xa inhibitors
    Jing Tao
    Elena N. Bukanova
    Shamsuddin Akhtar
    Journal of Intensive Care, 6
  • [25] Safety of 4-factor prothrombin complex concentrate (4F-PCC) for emergent reversal of factor Xa inhibitors
    Tao, Jing
    Bukanova, Elena N.
    Akhtar, Shamsuddin
    JOURNAL OF INTENSIVE CARE, 2018, 6
  • [26] Reversal of rivaroxaban-induced anticoagulation with prothrombin complex concentrate, activated prothrombin complex concentrate and recombinant activated factor VII in vitro
    Perzborn, Elisabeth
    Heitmeier, Stefan
    Laux, Volker
    Buchmueller, Anja
    THROMBOSIS RESEARCH, 2014, 133 (04) : 671 - 681
  • [27] Assessing efficacy of four factor prothrombin complex concentrate (4FPCC) for reversal of direct factor Xa inhibitors in intracranial hemorrhages at an academic medical center
    Coppiano, Lindsey
    Wood, Kendyl Caroline
    Rocker, Jody
    Garcia, Klepper Alfredo
    Shah, Manan
    NEUROLOGY, 2020, 94 (15)
  • [28] LOW-DOSE FOUR-FACTOR PROTHROMBIN COMPLEX CONCENTRATE IN REVERSAL OF XA INHIBITORS IN A NEURO-ICU
    Allison, Teresa
    Hartman, Heather
    Gass, Jennifer
    Lin, Pei Jen
    Chong, Kenneth
    Choi, Huimahn
    Escobar, Miguel
    CRITICAL CARE MEDICINE, 2016, 44 (12)
  • [29] Prothrombin complex concentrate for reversal of direct factor Xa inhibitors prior to emergency surgery or invasive procedure: a retrospective study
    Siavash Piran
    Caroline Gabriel
    Sam Schulman
    Journal of Thrombosis and Thrombolysis, 2018, 45 : 486 - 495
  • [30] Prothrombin complex concentrate for reversal of direct factor Xa inhibitors prior to emergency surgery or invasive procedure: a retrospective study
    Piran, Siavash
    Gabriel, Caroline
    Schulman, Sam
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2018, 45 (04) : 486 - 495
12345